In Taipei, an increasing number of people are turning to cancer marker tests as part of their routine health screenings. Unlike diagnostic imaging or biopsies, which are typically used after symptoms appear, cancer marker tests analyze specific proteins or molecules in the blood that may indicate the presence of cancerous or precancerous cells. These biomarkers can offer a window into what's happening inside the body well before physical symptoms develop.

At Minsheng Medical Laboratory, which has been serving the Songshan District for over 35 years, technicians emphasize that cancer marker testing is not a standalone diagnostic tool. Rather, it works best when combined with other screening methods like imaging scans or physical examinations. Some common biomarkers include CEA (carcinoembryonic antigen) for colorectal cancer, CA-125 for ovarian cancer, and PSA (prostate-specific antigen) for prostate cancer.

One important consideration is that no biomarker is perfectly accurate. False positives can lead to unnecessary anxiety and further testing, while false negatives may create a false sense of security. This is why many healthcare professionals recommend annual screening for individuals over 40, especially those with a family history of cancer or other risk factors.

The process itself is simple: a small blood sample is drawn, usually in the morning after fasting, and sent to a laboratory for analysis. Results typically come back within a few days. Some people prefer to schedule their appointments through online platforms like SimplyBook, which many local clinics and labs now use for convenience.

Early detection remains one of the most effective ways to improve treatment outcomes. While cancer marker tests are not foolproof, they serve as a valuable first step in identifying potential issues. For anyone considering this type of screening, consulting a healthcare provider for personalized advice based on age, family history, and lifestyle factors is strongly recommended.